These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 11196149

  • 1. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS.
    Cancer Res; 2001 Jan 01; 61(1):126-30. PubMed ID: 11196149
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 01; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR.
    Gynecol Oncol; 2001 Dec 01; 83(3):575-85. PubMed ID: 11733975
    [Abstract] [Full Text] [Related]

  • 8. Energy balance and colon cancer--beyond physical activity.
    Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD.
    Cancer Res; 1997 Jan 01; 57(1):75-80. PubMed ID: 8988044
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F.
    Epidemiology; 1998 May 01; 9(3):295-300. PubMed ID: 9583422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F.
    J Clin Oncol; 2007 Dec 20; 25(36):5785-92. PubMed ID: 18089876
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 20; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA, Hoover RN.
    Obstet Gynecol; 1993 Feb 20; 81(2):265-71. PubMed ID: 8380913
    [Abstract] [Full Text] [Related]

  • 20. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study.
    Elliott AM, Hannaford PC.
    Contraception; 2006 Apr 20; 73(4):331-5. PubMed ID: 16531161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.